MEDPLARGE

Medpace Holdings, Inc.

HealthcareMedical - Diagnostics & Research
$426.79
$0.04(-0.82%)
52W$284.10
$628.92
Updated May 6, 12:00 AM
RSI42
RS Rating23/99
Beta1.26
Volatility70%
F-Score6/9
Mkt Cap$12.2B
WEAKENING

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

WEAKENING

Medpace Holdings, Inc. is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 23), showing significant lag compared to the market leaders. Earnings growth of 17% provides fundamental context to the price action. Investors should exercise caution due to high volatility (70% annualized), which requires wider risk management.

Relative Strength
23
out of 99
Lagging
Trend Score
1/4
Minervini Criteria
WEAKENING
Risk (Beta)
1.26
vs S&P 500
ABOVE MKT
52W Position
41%
from 52W low
Lower Half
Trend & Momentum Analysis

Trend Template (Minervini)

WEAKENING1/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$465.95
50 SMA > 100 SMA$509.37
100 SMA > 150 SMA$529.05
150 SMA > 200 SMA$514.15

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$464.09-8.04%BELOW
50 SMA$465.95-8.40%BELOW
100 SMA$509.37-16.21%BELOW
150 SMA$529.05-19.33%BELOW
200 SMA$514.15-16.99%BELOW

Price Performance

1D-0.8%
1W+3.2%
1M-14.0%
3M-21.3%
6M-27.9%
YTD-25.3%
1Y+47.8%
3Y+26.8%
52-Week Trading Range41% from low
$426.79
52W Low$284.10
52W High$628.92

Technical Indicators

RSI (14)NEUTRAL
41.5
305070
VCP ScoreCOOL
3/10
Base depth: 36.9%

Risk Profile

Beta
1.26
52W Vol
70%
ATR
$24.54
Max DD (1Y)
-37%

Volume Analysis

Today
349.2K
50D Avg
372.0K
Vol Ratio
0.94x
Liquidity
LIQUID

Earnings Momentum

Q2'25+13%
$3.10
Q3'25+29%
$3.87
Q4'25+27%
$4.67
Q1'26+17%
$4.28
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:+21.56%
5 Years:+22.27%
3 Years:+20.12%
TTM:+24.19%

Compounded Profit Growth

10 Years:
5 Years:+31.81%
3 Years:+28.04%
TTM:+21.53%

Stock Price CAGR

10 Years:+31.41%
5 Years:+21.09%
3 Years:+26.76%
1 Year:+47.80%

Return on Equity

10Y Avg:30.3%
5Y Avg:49.2%
3Y Avg:62.8%
Last Year:120.9%

Key Metrics

Market Cap$12.2B
Gross Margin30.1%
Net Margin17.8%
Piotroski F-Score6/9

Frequently Asked Questions

Is MEDP in an uptrend right now?

MEDP has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.

Is MEDP overbought or oversold?

MEDP's RSI (14) is 42. The stock is in neutral territory, neither overbought nor oversold.

Is MEDP outperforming the market?

MEDP has a Relative Strength (RS) Rating of 23 out of 99. MEDP is currently lagging the broader market.

Where is MEDP in its 52-week range?

MEDP is trading at $426.79, which is 68% of its 52-week high ($628.92) and 41% above its 52-week low ($284.10).

How volatile is MEDP?

MEDP has a Beta of 1.26 and 52-week volatility of 70%. It's more volatile than the S&P 500 - expect bigger swings.

Disclaimer: Data is for informational purposes only. May be delayed or contain errors. Past performance does not guarantee future results. This is not financial advice. Always conduct your own research and consult professionals before making investment decisions.